Insiders Buying Chart Industries And 2 Other Stocks
Although U.S. stocks closed mostly higher on Friday, there were a few notable insider trades.
Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Yield10 Bioscience (NASDAQ:YTEN) shares rose 104.4% to $0.46 during Thursday’s regular session. The market value of their…
Earnings Scheduled For December 6, 2023
Companies Reporting Before The Bell
• Ollie's Bargain Outlet (NASDAQ:OLLI) is estimated to report quarterly earnings at $0.44 per share on revenue of $468.55 million.
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Trxade Health (NASDAQ:MEDS) shares moved upwards by 76.2% to $13.46 during Monday’s pre-market session. The company’s market…
Kewaunee Scientific Corporation Announces Continued Backlog Growth With Indian Oil Corporation Contract; No Financial Terms Disclosed
Kewaunee Scientific Corporation (NASDAQ:KEQU), a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, today announces that the
Kewaunee Scientific Q2 EPS $(0.09) Up From $(1.11) YoY, Sales $54.56M Up From $39.03M YoY
Kewaunee Scientific (NASDAQ:KEQU) reported quarterly losses of $(0.09) per share. This is a 91.89 percent increase over losses of $(1.11) per share from the same period last year. The company reported $54.56 million in
Kewaunee Scientific Q1 EPS $(0.27) Up From $(0.48) YoY, Sales $50.12M Up From $39.49M YoY
Kewaunee Scientific (NASDAQ:KEQU) reported quarterly losses of $(0.27) per share. This is a 43.75 percent increase over losses of $(0.48) per share from the same period last year. The company reported $50.12 million in
Akerna Shares Dip 53%, Here’s 78 Biggest Movers From Yesterday
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.